期刊文献+

TGF-β信号通路与口腔鳞状细胞癌的研究进展 被引量:2

Research progress about role of TGF-β signaling pathway in oral squamous cell carcinoma
原文传递
导出
摘要 转化生长因子β(TGF-β)是一个调节上皮细胞增殖、免疫功能和新血管生成的关键分子,TGF-β及其信号通路在维持上皮细胞内环境稳态时发挥重要作用。TGF-β信号通路的失调在众多恶性肿瘤中均可见,包括口腔鳞状细胞癌(OSCC)。TGF-β信号通路的失调会导致细胞过度增殖并抑制细胞凋亡,基因组不稳定性增强,促进肿瘤上皮间质转化。而肿瘤炎症微环境中TGF-β会代偿性升高,提高肿瘤细胞的增殖及迁移能力,促进癌巢内的新血管生成,增强炎症对肿瘤的促进作用。本文就TGF-β信号通路在OSCC发生、发展中所发挥的作用做一综述。 Transforming growth factor-β (TGF-β) is a key regulator of epithelial cell proliferation,immune function and angiogenesis.Because TGF-β signaling maintains epithelial homeostasis,dysregulated TGF-β signaling is common in many malignancies,including oral squamous cell carcinoma (OSCC).Defective TGF-β signaling in epithelial cells causes hyperproliferation,reduced apoptosis and increased genomic instability,and the compensatory increase in TGF-β production by tumor epithelial cells with TGF-β signaling defects further promotes tumor growth and metastases by increasing angiogenesis and inflammation in tumor stromal cells.We review the role of TGF-β signaling in the development of OSCC.
出处 《中华口腔医学研究杂志(电子版)》 CAS 2014年第3期61-64,F0003,共5页 Chinese Journal of Stomatological Research(Electronic Edition)
基金 广东省自然科学基金(S2012010010382) 深圳市创新委国际合作项目(ZYA201106100080A) 深圳市创新委基础研究(JCY20130402114702120)
关键词 转化生长因子Β 口腔鳞状细胞癌 Smad家族蛋白 Transforming growth factor-β Oral squamous cell carcinoma Smad
  • 相关文献

参考文献1

二级参考文献108

  • 1Hagedorn HG, Bachmeier BE, Nerlich AG. Synthesis and degradation of basement membranes and extracellular matrix and their regulation by TGF-beta in invasive carcinomas. Int J Oncol 2001; 18:669-681.
  • 2Dickson MC, Martin JS, Cousins FM, Kulkami AB, Karlsson S, Akhurst RJ. Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice. Development 1995; 121:1845-1854.
  • 3Larsson J, Goumans M J, Sjostrand L J, et al. Abnormal angiogenesis but intact hematopoietic potential in TGF-beta type Ⅰ receptor-deficient mice. EMBO J 2001; 20:1663-1673.
  • 4Oshima M, Oshima H, Taketo MM. TGF-beta receptor type Ⅱ deficiency results in defects of yolk sac hematopoiesis and vasculogenesis. Dev Biol 1996; 179:297-302.
  • 5Steams ME, Garcia FU, Fudge K, Rhim J, Wang M. Role of interleukin 10 and transforming growth factor betal in the angiogenesis and metastasis of human prostate primary tumor lines from orthotopic implants in severe combined irnmunodeficiency mice. Clin Cancer Res 1999: 5:711-720.
  • 6Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002; 2:442-454.
  • 7Derynck R, Akhurst RJ. Differentiation plasticity regulated by TGF-beta family proteins in development and disease. Nat Cell Biol 2007; 9:1000-1004.
  • 8Miettinen P J, Ebner R, Lopez AR, Derynck R. TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal ceils: involvement of type Ⅰ receptors. J Cell Biol 1994; 127:2021-2036.
  • 9Oft M, Peli J, Rudaz C, Schwarz H, Beug H, Reichmann E. TGF-betal and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells. Genes Dev 1996; 10:2462-2477.
  • 10Ozdamar B, Bose R, Barrios-Rodiles M, Wang HR, Zhang Y, Wrana JL. Regulation of the polarity protein Par6 by TGF- beta receptors controls epithelial cell plasticity. Science 2005; 307:1603-1609.

共引文献55

同被引文献18

  • 1Huang J, Yao X, Zhang J, et al . Hypoxia-induced downregu- lation of miRNA-93 promotes epithelial mesenchymal transi- tion in human renal cell carcinoma[J]. Cancer Sci, 2013, 104 (12):1609 -1617.
  • 2Melo SA,Esteller M. Dysregulation of microRNAs in cancer: playing with fire[J]. FEBS Lett, 2010,585(13) : 2087-2099.
  • 3Xia Y, Chen Q, Zhong Z, et al .Down regulation of miRNA-93 promotes the invasion of non-small cell lung cancer by targeting MTAI[J].Cell Physiol Biochem, 32(2):476-485.
  • 4Mu YP,Su XL. Polymorphism in pre-miRNA-93contributes to hepatocellular carcinoma risk in a chinese population[J]. Med Oncol, 2012,29(3):1723- 1732.
  • 5Tasoulas J , Giaginis C,Patsouris E, et al. Histone deacetylase inhibitors in oral squamous cell carcinoma treatment[J], Ex?pert Opin lnvestig Drugs,2014, 12(1): 1-10.
  • 6Chuang WY, Yeh CJ, Chao YK, et al. Concordant podo?planin expression in cancer-associated fibroblasts and tumor cells is an adverse prognostic factor in esophageal squamous cell carcinoma[J]. lnt J Clin Exp Pathol , 2014, 7(8) :4847-4856.
  • 7Lindgren G,Ekblad L, Vallon-Christersson J ,et aL Eryth?ropoietin suppresses the activation of pro-apoptotic genes in head and neck squamous cell carcinoma xenografts ex?posed to surgical trauma[J]. BMC Cancer, 2014, 14 (1) : 648-649.
  • 8Lai YH, He RY, Chou JL, et al. Promoter hyperrnethyla?tion and silencing of tissue factor pathway inhibitor-2 in oral squamous cell carcinomaj L], J Transl Med , 2014, 12 (1) :237-238.
  • 9Garewal J , Garewal R, Sircar K, et al. Expression of Bcl- 2 and MlB-1 Markers in Oral Squamous Cell Carcinoma (OSCC)-A Comparative Study [J]. J Clin Diagn Res, 2014,8(7): 1-4.
  • 10Wang X, Sun C, He S, et al. Apoptotic effects of diosgen?inlactoside on oral squamous carcinoma cells in vitro and in vivol.J]. BioI Pharm Bull, 2014,37 (9) : 1450-1459.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部